Humer Franz B has filed 6 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 95400 shares of Allogene Therapeutics, Inc. ($ALLO) on June 18, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 18, 2025 | Allogene Therapeutics, Inc. | $ALLO | Humer Franz B | Director | A | Restricted Stock Unit | 95400 | $0.00 | 95,400.0000 | 217,264,738 | 9999.99% | 0.04% |
| Dec. 5, 2024 | Allogene Therapeutics, Inc. | $ALLO | Humer Franz B | Director | S | Common Stock | 9221 | $2.16 | 307,507.0000 | 0 | 2.91% | 0.00% |
| June 5, 2024 | Allogene Therapeutics, Inc. | $ALLO | Humer Franz B | Not found | A | Common Stock | 61475 | $0.00 | 316,728.0000 | 0 | 24.08% | 0.00% |
| June 5, 2024 | Allogene Therapeutics, Inc. | $ALLO | Humer Franz B | Not found | A | Stock Option (Right to buy) | 95541 | $0.00 | 95,541.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Allogene Therapeutics, Inc. | $ALLO | Humer Franz B | Not found | S | Common Stock | 11200 | $2.34 | 255,253.0000 | 0 | 4.20% | 0.00% |
| June 13, 2023 | Allogene Therapeutics, Inc. | $ALLO | Humer Franz B | Not found | A | Common Stock | 74561 | $0.00 | 266,453.0000 | 0 | 38.86% | 0.00% |